$SBRA
Sabra Health Care REIT, Inc.

2022 Q3 Form 10-Q Financial Statement

#000149229822000027 Filed on August 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $140.8M $156.0M $163.1M
YoY Change 9.47% 1.98% 7.05%
Cost Of Revenue $36.71M $34.03M $33.10M
YoY Change 22.51% 19.39% 15.75%
Gross Profit $104.1M $121.9M $130.0M
YoY Change 5.5% -1.61% 5.09%
Gross Profit Margin 73.92% 78.18% 79.7%
Selling, General & Admin $9.459M $8.379M $10.87M
YoY Change 9.26% -0.27% -1.17%
% of Gross Profit 9.09% 6.87% 8.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $47.43M $45.17M $45.26M
YoY Change 5.29% 1.53% 1.99%
% of Gross Profit 45.58% 37.05% 34.81%
Operating Expenses $62.01M $58.40M $61.14M
YoY Change 5.49% 0.88% 0.89%
Operating Profit $42.05M $63.53M $68.86M
YoY Change 5.52% -3.8% 9.13%
Interest Expense -$31.46M -$28.06M -$27.77M
YoY Change 11.3% -85.54% -4.23%
% of Operating Profit -74.8% -44.17% -40.33%
Other Income/Expense, Net $774.0K -$6.664M -$203.0K
YoY Change 3973.68% 73.99% -131.09%
Pretax Income -$45.10M $19.59M $43.69M
YoY Change -414.67% -48.09% 11.57%
Income Tax $579.0K $255.0K $284.0K
% Of Pretax Income 1.3% 0.65%
Net Earnings -$50.06M $16.81M $40.60M
YoY Change -589.72% -112.68% 21.39%
Net Earnings / Revenue -35.57% 10.78% 24.89%
Basic Earnings Per Share -$0.22 $0.07 $0.18
Diluted Earnings Per Share -$0.22 $0.07 $0.18
COMMON SHARES
Basic Shares Outstanding 231.0M shares 231.0M shares 230.9M shares
Diluted Shares Outstanding 231.0M shares 231.7M shares 231.6M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.29M $67.15M $24.84M
YoY Change -95.19% -3.16% -0.26%
Cash & Equivalents $26.29M $67.15M $24.84M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $175.0M $246.8M $180.6M
YoY Change -74.4% -0.97% -15.37%
LONG-TERM ASSETS
Property, Plant & Equipment $5.019B $5.045B $5.156B
YoY Change -4.01% -4.26% -2.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $207.6M $219.9M $93.88M
YoY Change 88.84% 92.98% -66.92%
Other Assets $4.859M $4.368M $4.443M
YoY Change -4.35% -4.8% -3.41%
Total Long-Term Assets $5.670B $5.715B $5.704B
YoY Change 2.6% 2.54% -0.8%
TOTAL ASSETS
Total Short-Term Assets $175.0M $246.8M $180.6M
Total Long-Term Assets $5.670B $5.715B $5.704B
Total Assets $5.845B $5.961B $5.885B
YoY Change -5.87% 2.39% -1.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $123.2M $101.1M $92.90M
YoY Change 13.43% -2.17% -12.28%
Accrued Expenses $22.00M $16.60M $25.40M
YoY Change 20.88% 3.11% 44.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $145.2M $117.7M $118.3M
YoY Change 14.5% -1.45% -4.21%
LONG-TERM LIABILITIES
Long-Term Debt $2.447B $2.480B $2.358B
YoY Change -9.44% 9.44% 3.33%
Other Long-Term Liabilities $44.02M $45.80M $47.58M
YoY Change -14.57% -14.14% -14.11%
Total Long-Term Liabilities $2.491B $2.526B $2.405B
YoY Change -9.54% 8.9% 2.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $145.2M $117.7M $118.3M
Total Long-Term Liabilities $2.491B $2.526B $2.405B
Total Liabilities $2.636B $2.644B $2.523B
YoY Change -8.48% 8.39% 2.56%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.310M $2.310M $2.310M
YoY Change 4.57% 4.62% 6.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.209B $3.318B $3.362B
YoY Change
Total Liabilities & Shareholders Equity $5.845B $5.961B $5.885B
YoY Change -5.87% 2.39% -1.32%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$50.06M $16.81M $40.60M
YoY Change -589.72% -112.68% 21.39%
Depreciation, Depletion And Amortization $47.43M $45.17M $45.26M
YoY Change 5.29% 1.53% 1.99%
Cash From Operating Activities $108.5M $76.57M $63.11M
YoY Change 2.14% -8.59% -7.9%
INVESTING ACTIVITIES
Capital Expenditures -$63.41M $0.00 -$20.57M
YoY Change 704477.78% -100.0% -28.32%
Acquisitions
YoY Change
Other Investing Activities $6.423M -$90.86M -$16.67M
YoY Change -4410.74% 981.5% 148.79%
Cash From Investing Activities -$56.99M -$90.86M -$37.24M
YoY Change 35968.99% 117.32% 5.33%
FINANCING ACTIVITIES
Cash Dividend Paid $69.28M
YoY Change 9.58%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -91.62M 55.95M -$112.5M
YoY Change -124.66% 2142.53% 62.42%
NET CHANGE
Cash From Operating Activities 108.5M 76.57M $63.11M
Cash From Investing Activities -56.99M -90.86M -$37.24M
Cash From Financing Activities -91.62M 55.95M -$112.5M
Net Change In Cash -40.15M 41.66M -$86.65M
YoY Change -108.41% -6.28% 140.01%
FREE CASH FLOW
Cash From Operating Activities $108.5M $76.57M $63.11M
Capital Expenditures -$63.41M $0.00 -$20.57M
Free Cash Flow $171.9M $76.57M $83.69M
YoY Change 61.84% -34.65% -13.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001492298
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#HealthCareResidentServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#HealthCareResidentServiceMember
CY2021Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#HealthCareResidentServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#HealthCareResidentServiceMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34950
dei Entity Registrant Name
EntityRegistrantName
SABRA HEALTH CARE REIT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2560479
dei Entity Address Address Line1
EntityAddressAddressLine1
18500 Von Karman Avenue, Suite 550
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
393-8248
dei Security12b Title
Security12bTitle
Common stock, $.01 par value
dei Trading Symbol
TradingSymbol
SBRA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
230968872 shares
CY2022Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
897568000 usd
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
831324000 usd
CY2022Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5045129000 usd
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5162884000 usd
CY2022Q2 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
395342000 usd
CY2021Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
399086000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
219920000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
96680000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67153000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111996000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4368000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3890000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
49836000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54063000 usd
CY2022Q2 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
179684000 usd
CY2021Q4 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
138108000 usd
CY2022Q2 us-gaap Assets
Assets
5961432000 usd
CY2021Q4 us-gaap Assets
Assets
5966707000 usd
CY2022Q2 us-gaap Secured Debt
SecuredDebt
50177000 usd
CY2021Q4 us-gaap Secured Debt
SecuredDebt
66663000 usd
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
142341000 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q2 us-gaap Loans Payable To Bank
LoansPayableToBank
553695000 usd
CY2021Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
594246000 usd
CY2022Q2 us-gaap Unsecured Debt
UnsecuredDebt
1734008000 usd
CY2021Q4 us-gaap Unsecured Debt
UnsecuredDebt
1733566000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
117682000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
142989000 usd
CY2022Q2 us-gaap Below Market Lease Net
BelowMarketLeaseNet
45803000 usd
CY2021Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
49713000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Liabilities
Liabilities
2643706000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2587177000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
230968872 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
230968872 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
230398655 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
230398655 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2310000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2304000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4482239000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4482451000 usd
CY2022Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1176968000 usd
CY2021Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1095204000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10145000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10021000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3317726000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3379530000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5961432000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5966707000 usd
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
103168000 usd
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
110783000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
213054000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
224166000 usd
CY2022Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8653000 usd
CY2021Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
3031000 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
19645000 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5972000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44136000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39118000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86363000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75159000 usd
CY2022Q2 us-gaap Revenues
Revenues
155957000 usd
CY2021Q2 us-gaap Revenues
Revenues
152932000 usd
us-gaap Revenues
Revenues
319062000 usd
us-gaap Revenues
Revenues
305297000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45172000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44491000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
90428000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88866000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
25530000 usd
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
24270000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
50502000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
48713000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8649000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8811000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19045000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17749000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
11745000 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-270000 usd
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-109000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
205000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1916000 usd
CY2022Q2 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
11745000 usd
CY2021Q2 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2022Q2 sbra Operating And Interest Expense
OperatingAndInterestExpense
129704000 usd
CY2021Q2 sbra Operating And Interest Expense
OperatingAndInterestExpense
111364000 usd
sbra Operating And Interest Expense
OperatingAndInterestExpense
248918000 usd
sbra Operating And Interest Expense
OperatingAndInterestExpense
225225000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-54000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-271000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-847000 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2163000 usd
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-24000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2095000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
109000 usd
CY2022Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-4501000 usd
CY2021Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-3752000 usd
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-4501000 usd
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-2439000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6664000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3830000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6867000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3177000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19589000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37738000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
63277000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
76895000 usd
CY2022Q2 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-2529000 usd
CY2021Q2 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-169789000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
522000 usd
sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-5331000 usd
sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-174799000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
255000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
539000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1222000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
16805000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-132573000 usd
us-gaap Net Income Loss
NetIncomeLoss
57407000 usd
us-gaap Net Income Loss
NetIncomeLoss
-99126000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230967163 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216264207 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230913462 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213870329 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231681536 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216264207 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231641958 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213870329 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
16805000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-132573000 usd
us-gaap Net Income Loss
NetIncomeLoss
57407000 usd
us-gaap Net Income Loss
NetIncomeLoss
-99126000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3081000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-218000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2437000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-469000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5390000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-9583000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
17729000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
24206000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8471000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9801000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20166000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23737000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25276000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-142374000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
77573000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75389000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3503404000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-132573000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9801000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2857000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84591000 usd
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
65415000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3383063000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3361523000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
16805000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8471000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1183000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-578000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
69678000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3317726000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3409228000 usd
us-gaap Net Income Loss
NetIncomeLoss
-99126000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23737000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5692000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
172715000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
us-gaap Dividends Common Stock
DividendsCommonStock
129183000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3383063000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3379530000 usd
us-gaap Net Income Loss
NetIncomeLoss
57407000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20166000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3856000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-4062000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
us-gaap Dividends Common Stock
DividendsCommonStock
139171000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3317726000 usd
us-gaap Net Income Loss
NetIncomeLoss
57407000 usd
us-gaap Net Income Loss
NetIncomeLoss
-99126000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
90428000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88866000 usd
sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-8061000 usd
sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-10627000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1094000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
914000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5502000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3645000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3250000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4559000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-271000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-847000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
205000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1916000 usd
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-4501000 usd
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-2439000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
11745000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
164126000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5331000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10673000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2167000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6074000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2361000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25895000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11777000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
139683000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
152266000 usd
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
20573000 usd
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
62107000 usd
sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
4990000 usd
sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
3394000 usd
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
19495000 usd
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
21736000 usd
sbra Payments For Escrow Deposits For Potential Investments
PaymentsForEscrowDepositsForPotentialInvestments
836000 usd
sbra Payments For Escrow Deposits For Potential Investments
PaymentsForEscrowDepositsForPotentialInvestments
0 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
4466000 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1135000 usd
sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-1333000 usd
sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-513000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
128007000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
40003000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8381000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-128099000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77208000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
142353000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
40000000 usd
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
110000000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
16547000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1446000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
6000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7000 usd
sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
-3803000 usd
sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
172698000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
138565000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
128050000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56568000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66805000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-44984000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8253000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
619000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115886000 usd
CY2022Q2 sbra Real Estate Investments Joint Ventures Number
RealEstateInvestmentsJointVenturesNumber
0 investment
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65523000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71521000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73935000 usd
us-gaap Interest Paid Net
InterestPaidNet
49968000 usd
us-gaap Interest Paid Net
InterestPaidNet
45658000 usd
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
5623000 usd
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 usd
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
CY2022Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5942697000 usd
CY2022Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
897568000 usd
CY2022Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5045129000 usd
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5994208000 usd
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
831324000 usd
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5162884000 usd
CY2022Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5101294000 usd
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5145096000 usd
CY2022Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
265594000 usd
CY2021Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
262969000 usd
CY2022Q2 us-gaap Land Improvements
LandImprovements
4050000 usd
CY2021Q4 us-gaap Land Improvements
LandImprovements
4295000 usd
CY2022Q2 us-gaap Land
Land
571759000 usd
CY2021Q4 us-gaap Land
Land
581848000 usd
CY2022Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5942697000 usd
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5994208000 usd
CY2022Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
897568000 usd
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
831324000 usd
CY2022Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5045129000 usd
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5162884000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2022Q2 us-gaap Security Deposit Liability
SecurityDepositLiability
12200000 usd
CY2021Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
28600000 usd
CY2022Q2 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
79000000 usd
CY2021Q4 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
63000000 usd
CY2022Q2 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16900000 usd
CY2021Q4 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16800000 usd
CY2022Q2 us-gaap Variable Lease Income
VariableLeaseIncome
4400000 usd
us-gaap Variable Lease Income
VariableLeaseIncome
9400000 usd
CY2021Q2 us-gaap Variable Lease Income
VariableLeaseIncome
4800000 usd
us-gaap Variable Lease Income
VariableLeaseIncome
9600000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
196502000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
390351000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
391434000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
386768000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
371249000 usd
CY2022Q2 sbra Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
1464368000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3200672000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
219920000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
96680000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
11700000 usd
sbra Disposal Group Including Discontinued Operations Number Of Properties
DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties
8 facility
sbra Disposal Group Including Discontinued Operations Number Of Properties
DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties
4 facility
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
40000000.0 usd
CY2021Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
11300000 usd
CY2022Q2 sbra Disposal Group Including Discontinued Operation Assets And Liabilities Net
DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet
44500000 usd
CY2021Q2 sbra Disposal Group Including Discontinued Operation Assets And Liabilities Net
DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet
14700000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-4500000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-3400000 usd
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-3200000 usd
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-1800000 usd
CY2022Q2 sbra Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
14 loan
CY2022Q2 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
347693000 usd
CY2022Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
343881000 usd
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
348375000 usd
CY2022Q2 sbra Financing Receivable Fixed Interest Rate
FinancingReceivableFixedInterestRate
0.076
CY2022Q2 sbra Financing Receivable Effective Interest Rate
FinancingReceivableEffectiveInterestRate
0.075
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6612000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6344000 usd
CY2022Q2 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
347693000 usd
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
337269000 usd
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
342031000 usd
CY2022Q2 sbra Preferred Equity Investments Number
PreferredEquityInvestmentsNumber
8 preferredequityinvestment
CY2022Q2 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
57861000 usd
CY2022Q2 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
58073000 usd
CY2021Q4 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
57055000 usd
CY2022Q2 sbra Preferred Equity Investment Weighted Average Contractual Rate
PreferredEquityInvestmentWeightedAverageContractualRate
0.110
CY2022Q2 sbra Preferred Equity Investment Weighted Average Effective Rate
PreferredEquityInvestmentWeightedAverageEffectiveRate
0.109
CY2022Q2 sbra Number Of Investments
NumberOfInvestments
22 investment
CY2022Q2 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
405554000 usd
CY2022Q2 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
395342000 usd
CY2021Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
399086000 usd
CY2022Q2 sbra Investments Weighted Average Contractual Rate
InvestmentsWeightedAverageContractualRate
0.080
CY2022Q2 sbra Investments Weighted Average Effective Rate
InvestmentsWeightedAverageEffectiveRate
0.080
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-200000 usd
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
300000 usd
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-100000 usd
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1800000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6600000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6300000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
25500000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
50500000 usd
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
24300000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
48700000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2800000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5500000 usd
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1700000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3600000 usd
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16600000 usd
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
21500000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
969000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
144320000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
558997000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2089000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
502147000 usd
CY2022Q2 sbra Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1291874000 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2500396000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3207000 usd
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
16968000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
2480221000 usd
CY2022Q2 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
10618000 usd
CY2021Q2 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-15039000 usd
sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
17767000 usd
sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
13848000 usd
CY2022Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
14976000 usd
CY2022Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2022Q2 us-gaap Derivative Assets
DerivativeAssets
14976000 usd
CY2022Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
0 usd
CY2022Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 usd
CY2022Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
14976000 usd
CY2022Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 usd
CY2022Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2022Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0 usd
CY2022Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 usd
CY2022Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
0 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
3330000 usd
CY2021Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
3330000 usd
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
930000 usd
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
2400000 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
3726000 usd
CY2021Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
3726000 usd
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
930000 usd
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
2796000 usd
CY2022Q2 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
347693000 usd
CY2021Q4 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
352159000 usd
CY2022Q2 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
57861000 usd
CY2021Q4 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
56805000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3300000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1900000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
16805000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-132573000 usd
us-gaap Net Income Loss
NetIncomeLoss
57407000 usd
us-gaap Net Income Loss
NetIncomeLoss
-99126000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230967163 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216264207 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230913462 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213870329 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
714373 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
728496 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231681536 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216264207 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231641958 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213870329 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46

Files In Submission

Name View Source Status
0001492298-22-000027-index-headers.html Edgar Link pending
0001492298-22-000027-index.html Edgar Link pending
0001492298-22-000027.txt Edgar Link pending
0001492298-22-000027-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbra-20220630.htm Edgar Link pending
sbra-20220630.xsd Edgar Link pending
sbra-20220630_cal.xml Edgar Link unprocessable
sbra-20220630_def.xml Edgar Link unprocessable
sbra-20220630_htm.xml Edgar Link completed
sbra-20220630_lab.xml Edgar Link unprocessable
sbra-20220630_pre.xml Edgar Link unprocessable
sbraex3112022q2.htm Edgar Link pending
sbraex3122022q2.htm Edgar Link pending
sbraex3212022q2.htm Edgar Link pending
sbraex3222022q2.htm Edgar Link pending
Show.js Edgar Link pending